Epoch Biodesign
PrivateLast Round
Strategic
Mar 25, 2026
Total Funding Raised
$45.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Epoch Biodesign is a biotechnology company that develops AI-designed enzymes for the biorecycling of mixed plastics and textiles.
Sector
Energy & Sustainability
Verticals
Biotechnology, Circular Economy, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epoch Biodesign Comparables
Compare Epoch Biodesign with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Samsara Eco | 91% | |
| Evoralis | 82% | |
| Breaking | 81% |
Epoch Biodesign Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 25, 2026 | ||||
| Series A | Mar 5, 2025 | ||||
| Grant | Mar 5, 2025 | ||||
| Seed | Jun 22, 2022 | ||||
| Pre Seed | Jan 13, 2021 | ||||
Pre Seed | Dec 1, 2020 |
Epoch Biodesign Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Amadeus Capital Partners | Seed |
| Mundi Ventures | Series A |
| Ascension Ventures | Pre Seed |
| Voyagers.io | Seed |
| Plug and Play Tech Center | Pre Seed |
| Happiness Capital | Series A, Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 40% QoQ, from 57 to 80 employees.
- Apr 22, 2026
Launched Europe's first nylon 6,6 biorecycling demonstration plant.
Recent news
Latest coverage and updates
- expands_facilitiesAug 7, 2026
Epoch Biodesign Ltd. expanded facilities to Spain, Southern Europe, Europe on Jan 1st '26.
- invests_into_assetsAug 6, 2026
Epoch Biodesign Ltd. invested into assets: 52,000-tonne-a-year in the amount of $4.62M in Blanes, 17300, Spain, Southern Europe, Europe on Jan 1st '26.
- expands_facilitiesAug 3, 2026
Epoch Biodesign Ltd. was planning to expand facilities to Spain, Southern Europe, Europe on Jul 30th '26.
- expands_facilitiesAug 3, 2026
Epoch Biodesign Ltd. is planning to expand facilities to Spain, Southern Europe, Europe.
- expands_facilitiesAug 3, 2026
Epoch Biodesign Ltd. was planning to expand facilities to London, United Kingdom, Northern Europe, Europe on Jul 1st '26.
Epoch Biodesign Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Epoch Biodesign's valuation, stock price, and market status.
Is Epoch Biodesign a public or private company?
Epoch Biodesign is a private company.
What is the current stock price of Epoch Biodesign?
Epoch Biodesign is a private company with no public stock price. No recent secondary market data is available.
How much is Epoch Biodesign worth (valuation)?
Valuation information for Epoch Biodesign is not publicly available.
Can I buy Epoch Biodesign stock?
Epoch Biodesign shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Epoch Biodesign's last funding round?
Epoch Biodesign's most recent funding round was Venture - Series Unknown on March 25, 2026.
Who are the main investors in Epoch Biodesign?
Key investors in Epoch Biodesign include Extantia, Lowercarbon Capital.
Will Epoch Biodesign IPO soon?
No public IPO plans have been announced for Epoch Biodesign.
How can I track Epoch Biodesign secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epoch Biodesign's secondary market activity and sign up for updates.